Cargando…
The Association of Metformin, Other Antidiabetic Medications, and Statins With the Prognosis of Colon Cancer in Patients With Type 2 Diabetes: A Retrospective Cohort Study
BACKGROUND: Use of metformin and statins have been associated with improved prognosis of colon cancer (CC) in patients with type 2 diabetes (T2D). We examined the survival from CC in relation to the use of metformin, other oral antidiabetic medications (ADM), insulin, and statins in T2D patients. MA...
Autores principales: | Erkinantti, Sami, Hautakoski, Ari, Sund, Reijo, Arffman, Martti, Urpilainen, Elina, Puistola, Ulla, Jukkola, Arja, Peeter, Karihtala, Läärä, Esa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703554/ https://www.ncbi.nlm.nih.gov/pubmed/36422298 http://dx.doi.org/10.1177/10732748221134090 |
Ejemplares similares
-
The Association of Metformin, Other Antidiabetic Medications and Statins on the Prognosis of Rectal Cancer in Patients with Type 2 Diabetes: A Retrospective Cohort Study
por: Erkinantti, Sami, et al.
Publicado: (2022) -
Association of antidiabetic medication and statins with breast cancer incidence in women with type 2 diabetes
por: Hosio, Mayu, et al.
Publicado: (2019) -
Association of antidiabetic medication and statins with survival from ductal and lobular breast carcinoma in women with type 2 diabetes
por: Hosio, Mayu, et al.
Publicado: (2021) -
Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: a retrospective cohort study
por: Urpilainen, Elina, et al.
Publicado: (2018) -
Metformin and ovarian cancer: the evidence
por: Urpilainen, Elina, et al.
Publicado: (2020)